Small-Molecule Drug Equipment & Supplies

With its first clinical study underway, Acousia is taking significant strides towards achieving its goal of developing novel medicines that enhance and preserve natural hearing for patients with ...

The on-body infusor for the subcutaneous application of small-molecule drugs is available for volumes up to 3 ml. It can be worn on the body. Typical applications are bolus and basal regimens over several ...

But traditional small molecules can only block one single domain function of the protein, which means that potential other functions remain intact and can continue to fuel disease processes. This is one reason why it is assumed that traditional small molecule drugs can sufficiently address only a ...

This belt-worn on-body drug delivery device for small-molecule drugs has been developed for our pharma partner EVER Pharma. The wearable device is used by Parkinson's disease patients for the administration of apomorphine to treat this long-term degenerative disorder of the central nervous system. ...

The Alucent NVS Vessel Restoration System is designed to create a natural, stent-like scaffold using the body’s own tissue and processes. An all-in-one, integrated procedural system, Alucent NVS combines standard angioplasty techniques with a small molecule drug that when photoactivated, promotes extracellular matrix protein linking inside ...

The versatility of Starpharma’s DEP® platform means it can be used with a wide range of therapies and types of molecules (e.g., small molecule drugs, peptides, antibodies, radioisotopes). This flexibility has allowed Starpharma to develop a range of DEP® radiotheranostics as well as its other DEP® programs. ...

With a starting minimum volume of 25 ml, the Micro Mixer range is the ideal tool to scale down your contained mixing processes under pressure or vacuum. Dissolution of expensive shear sensitive API's, proteins, Developing and processing small molecule and complex biologic drug candidates. Or just vacuum ...

Blow-Fill-Seal (BFS) is a globally-trusted aseptic packaging technology where the pharmaceutical-grade plastic container is made, filled with the liquid drug product, and sealed in a rapid, continuous process. BFS is used around the world to package billions of doses of both large and small molecule sterile drug products ...

Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs ...

RNA interference (RNAi) is a naturally occurring process by which RNA molecules inhibit gene expression either pre- or post-transcriptionally. The discovery of RNAi led to a better understanding of gene regulation and opened the door to exciting new applications in research and therapeutics. The 2006 Nobel price was awarded in recognition of this revolutionary ...

A microbiome is a collection of microorganisms (and their DNA) that occupy a particular location. The "human microbiome" is composed of trillions of tiny microbes (mostly bacteria) that thrive in our mouth, on our skin, and inside our gut. An individual's gut microbiome is a unique and diverse community of thousands of distinct bacterial species. The vast majority of these bacteria are not ...

Qualigen licensed the G4 selective transcription inhibitor platform from University College London (UCL) in 2022. The licensed technology comprises lead compound QN-302 (formerly SOP1812) and back-up compounds that target regulatory regions of cancer genes that down-regulate gene expression in multiple cancer pathways. Developed by Dr. Stephen Neidle and his group at UCL, the G4 binding concept ...

Siolta’s Precision Symbiotics Platform enables rapid LBP development. A platform focused on translating microbiome science into novel therapeutics for a healthier world. Siolta’s patient-centric platform leverages our internal expertise in microbiome data analysis, machine learning, anaerobic microbiology, and translational studies to rationally design and optimize multi-strain live ...

Secreted proteins are a proven class of biologics with tremendous therapeutic potential, as they regulate tissue repair and regeneration, organ development, and immune response to disease. The characteristics of secreted proteins render them a rich pool of drug candidates for chronic and age-related diseases. Our therapeutic approach is to unlock the potential of these proteins, ...

Discover our implantable drug delivery systems made of bioresorbable polymers that release precise quantities of therapeutic agents gradually over time. DSM is a global leader in biomedical materials science – experience that we are now using to create advanced sustained release drug products as implantable or injectable delivery forms. ...